Oncology Videos | pharmaphorum

Video

Oncology

Unlocking the future of epigenetics, with Carlos Buesa

Carlos Buesa, CEO of Oryzon Genomics, discusses exploring how epigenetics is reshaping the landscape of oncology and CNS therapies.

Oncology

Interview at ESMO 2025 with Dr Ebrahim Delpassand

ESMO25: On radiopharmaceutical possibilities in oncology, wi...

At ESMO 2025, pharmaphorum spoke with Dr Ebrahim Delpassand, CEO of RadioMedix.

Oncology

Interview at ESMO 2025 with Michael Lahn, iOnctura

ESMO25: On allosteric modulation in oncology, with Michael L...

At ESMO 2025, pharmaphorum had the pleasure of speaking with Michael Lahn, Chief Medical Officer at iOnctura.

Oncology

Interview at ESMO 2025 with Sandeep Reddy, Immunity Bio

ESMO25: Harnessing the innate and the adaptive immune respon...

As ESMO 2025 came to a close last month, pharmaphorum had the pleasure of catching up with Dr Sandeep Reddy, Chief Medical Officer at ImmunityBio.

Oncology

Interview at ESMO 2025 with Tadaaki Taniguchi

ESMO25: On next-generation bispecifics, with Tadaaki Taniguc...

At ESMO 2025 in Berlin, pharmaphorum spoke with Tadaaki Taniguchi, Chief Research & Development Officer at Astellas.

Oncology

Interview at ESMO 2025 with Inge Marie Svane

ESMO25: Immuno-therapies and translational research in oncol...

Dr Inge Marie Svane – Professor in Clinical cancer immune therapy and director of the translational research centre, CCIT, on IO Biotech's ESMO25 data

Unlocking the future of epigenetics, with Carlos Buesa

ESMO25: On radiopharmaceutical possibilities in oncology, wi...

ESMO25: On allosteric modulation in oncology, with Michael L...

ESMO25: Harnessing the innate and the adaptive immune respon...

ESMO25: On next-generation bispecifics, with Tadaaki Taniguc...

ESMO25: Immuno-therapies and translational research in oncol...

ESMO26: Takeda preps filings on CLDN18.2 gastric cancer data

Discover a new era of healthcare panel engagement: Grounded ...

Video

Editor's Picks